假设:癌症荷尔梅斯及其癌症治疗疗法的潜力
Michael Bordonaro1, Darina Lazarova1
1Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA 18509, USA.
Life (Basel, Switzerland)
|March 28, 2024
概括
主要瘤可以通过同时存在的抗性来抑制二次病变的生长. 这项研究假设这种现象是癌症化,这表明控制瘤植入用于癌症预防.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 霍尔梅西斯研究研究
背景情况:
- 主要瘤可以抑制二次病变的生长,这一过程被称为并发耐药性.
- 现有研究表明,同时存在抗性的各种机制,得到实验证据的支持.
研究的目的:
- 建议同时存在的耐药性是癌症hormesis的一个表现.
- 探索癌症hormesis的治疗潜力,以预防癌症.
主要方法:
- 基于hormesis原则的理论框架开发.
- 假设低剂量瘤细胞在赋予耐药性的作用.
- 为癌症hormesis的治疗应用提出战略.
主要成果:
- 同时的耐药性可能由癌症激增症解释,双相剂量反应.
- 低级或良性瘤细胞可能会对更具攻击性的癌症产生抵抗力.
- 该研究建议控制植入良性瘤作为预防策略.
结论:
- 癌症霍梅西斯为同时存在的抗药性提供了一种新的理论解释.
- 这种模式表明,通过受控的瘤植入,对癌症有潜在的预防方法.
- 需要进一步的研究来验证这些假设,并制定治疗策略.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


